Data shown is for informational purposes only and does not constitute investment advice. TopFund is not SEBI-registered. Consult a SEBI-registered advisor before investing.
GSP Crop Science IPO
Price Band
₹304.0–320.0
Issue Size
₹400.0 Cr
Lot Size
46 shares
Min Investment
₹14,720
GMP
+₹2.0 (0.62%)
Issue Price
₹320.0
GSP Crop Science IPO AI Summary
- GSP Crop Science IPO is listed on BSE, NSE in the Pesticides & Agrochemicals sector.
- Price band: ₹304.0–₹320.0 per share, lot size 46 shares (min. investment ₹14,720).
- Subscription window: 16 Mar–18 Mar 2026, listing on 24 Mar 2026.
- Current GMP is +₹2.0 (0.62%), an estimated listing price of ₹322 — unofficial and can change daily.
GSP Crop Science Limited is an established agrochemical company with a diverse product portfolio and strong market presence. The IPO aims to raise ₹400 Cr, primarily for debt repayment and corporate purposes, while the financial performance shows fluctuations in revenue and profit across reporting periods.
TopFund is not SEBI-registered — this is educational analysis, not personalized investment advice.
Important Dates
Subscription Status
Subscription data unavailable
GSP Crop Science IPO Grey Market Premium (GMP) Today
GMP
+₹2.0
GMP %
+0.62%
Est. Listing
₹322.0
Updated: 14 Jul 2026 15:52
About the Company
Incorporated in 1985, GSP Crop Science Limited is an agrochemical company engaged in the manufacturing of crop protection products including insecticides, herbicides, fungicides, and plant growth regulators. The company develops and supplies crop protection solutions aimed at improving farm productivity and supporting pest, weed, and disease management. Its offerings include both Formulations and Technicals, serving a wide range of agricultural applications across domestic and international markets. GSP Crop Science has built a diversified agrochemical portfolio through in-house product development, manufacturing, and distribution. The company serves a broad base of B2B customers, including leading agrochemical companies in India and overseas, supported by long-standing business relationships. As of September 30, 2024, the company held 507 product registrations for its agrochemical portfolio and owned 89 patents. Revenue generated from patented products during the six months ended September 30, 2024 stood at ₹1,441.11 million, contributing approximately 20.73% of total revenue. The company continues to invest in research and development to enhance existing products and develop new formulations and technicals. Its dedicated R&D facilities at Kathwada and Odhav support product testing, process development, commercialization, and the production of complex agrochemical chemistries. Business operations: Formulations: As of September 30, 2024, the company held 387 registrations for formulations. These products are made using active ingredients and additives and are available in both liquid and solid forms under owned brands and licensed products. Technicals: As of September 30, 2024, the company held 120 registrations for technicals, which are concentrated active ingredients used in the manufacturing of insecticides, herbicides, fungicides, and related agrochemical products. As of September 30, 2024, GSP Crop Science Limited employed 1,096 permanent employees. Competitive strengths: Diversified agrochemical portfolio across insecticides, herbicides, fungicides, and plant growth regulators. Established customer relationships with a broad domestic and international client base. Strong in-house R&D infrastructure focused on innovation and product development. Integrated manufacturing capabilities with emphasis on operational efficiency and sustainability. Experienced promoters and professional management team with extensive industry expertise.
Company Financials (₹ Cr)
As of 2025-09-30
| Period Ended | 30 Sep 2025 | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|---|
| Assets | 1,491.69 | 1,228.50 | 980.34 | 1,132.13 |
| Total Income | 847.61 | 1,301.06 | 1,158.23 | 1,206.05 |
| Profit After Tax | 81.07 | 81.42 | 55.54 | 17.57 |
| EBITDA | 138.86 | 164.03 | 130.41 | 81.28 |
| NET Worth | 529.85 | 450.03 | 370.46 | 363.47 |
| Reserves and Surplus | 490.84 | 411.02 | 344.46 | 336.00 |
| Total Borrowing | 321.13 | 295.60 | 235.44 | 324.26 |
Key Ratios
EPS
₹20.87
NAV
₹115.34
ROE
18.38%
ROCE
19.80%
P/B Value
2.77
P/E Ratio
15.34
Market Cap
₹1488.60 Cr
PAT Margin
6.26%
Debt/Equity
0.58
Promoters
Bhavesh Vrajmohan Shah, Tirth Kenal Shah, Vilasben Vrajmohan Shah, Falguni Kenal Shah, Alpha trust and Kappa Trust
Objects of the Issue
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects: # Issue Objects Est Amt (₹ Cr.) 1 Repayment or pre-repayment of all or a portion of certain outstanding borrowings availed by the Company 170.00 2 General Corporate Purpose 50.32 3 Issue Expenses 32.81 Total 253.12
IPO Evaluation
Generated 23 Sep 2026Revenue Trend
Total income was ₹1,206.05 Cr in the year ended 31 Mar 2023, decreasing to ₹1,158.23 Cr by 31 Mar 2024, then rising to ₹1,301.06 Cr as of 31 Mar 2025, and further decreasing to ₹847.61 Cr by 30 Sep 2025, though this is a 9-month figure, not a full year, so isn't directly comparable.
Profit Trend
Profit After Tax was ₹17.57 Cr in the year ended 31 Mar 2023, increasing to ₹55.54 Cr by 31 Mar 2024, slightly rising to ₹81.42 Cr as of 31 Mar 2025, and then decreasing to ₹81.07 Cr by 30 Sep 2025, though this is a 9-month figure, not a full year, so isn't directly comparable.
Grey Market Premium, Explained
The Grey Market Premium (GMP) indicates the expected listing price of an IPO based on unofficial trading before it officially lists on the stock exchange. A positive GMP suggests strong demand, while a negative GMP indicates weaker demand.
Who This IPO Suits
Investors comfortable with short-term volatility and a long-term horizon typically weigh IPOs like this against their overall investment strategy and risk tolerance. It's essential to consider the company's financial health, market position, and growth prospects.
Who May Want to Wait
Investors who prefer stable returns and are risk-averse may want to avoid IPOs like this, which can experience significant price fluctuations and uncertainties in the initial trading period.
IPO Timeline, Explained
The IPO process includes several key dates: the issue opens on 16 March 2026 and closes on 18 March 2026. Allotments will be finalized by 20 March 2026, and the shares are expected to list on the stock exchange on 24 March 2026.
Listing Gains — The Risk
Listing gains refer to the potential profit an investor can make when shares of an IPO are listed on the stock exchange, often at a price higher than the issue price. However, these gains are not guaranteed and can be influenced by market conditions, investor sentiment, and the company's performance post-listing.
This evaluation is generated from GSP Crop Science's own public IPO filing data for educational purposes and is not investment advice or a recommendation to apply, subscribe to, or avoid this issue — see Broker Recommendations below for named third-party research views (clearly attributed, not TopFund's own). TopFund is not a SEBI-registered investment adviser — see our Disclaimer.
Frequently Asked Questions
What is GSP Crop Science IPO GMP today?
GSP Crop Science IPO GMP today is +₹2.0 (0.62%), indicating an estimated listing price of ₹322. GMP is an unofficial grey-market indicator and can change daily.
What is the price band of GSP Crop Science IPO?
The price band of GSP Crop Science IPO is ₹304.0–₹320.0 per share.
When does GSP Crop Science IPO open and close?
GSP Crop Science IPO opens on 16 March 2026 and closes on 18 March 2026.
When does GSP Crop Science IPO list on the stock exchange?
GSP Crop Science IPO listed on 24 March 2026 at ₹322.0.
What is the lot size for GSP Crop Science IPO?
The lot size for GSP Crop Science IPO is 46 shares, requiring a minimum investment of ₹14,720.
What is the price band for the GSP Crop Science IPO?
The price band for the GSP Crop Science IPO is ₹304.0 to ₹320.0.
What is the minimum investment required?
The minimum investment required is ₹14,720, which corresponds to a lot size of 46 shares at the issue price of ₹320.0.
When does the IPO open and close?
The IPO opens on 16 March 2026 and closes on 18 March 2026.
What does GMP mean?
GMP stands for Grey Market Premium, which indicates the expected listing price of an IPO based on unofficial trading before it officially lists.
When is the listing date for the shares?
The shares are expected to be listed on 24 March 2026.
Issue Details
Investor Allocation
Registrar
Lead Managers / Book Running
IPO Timeline
Open
16 Mar 2026
Close
18 Mar 2026
Allotment
20 Mar 2026
Listing
24 Mar 2026
Similar IPOs in Pesticides & Agrochemicals
Plan Your IPO Investment
Related Articles
Community Sentiment
What are other investors planning for GSP Crop Science?
No votes yet — be the first to share your view.
Sign in to voteDiscussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
No comments yet — start the discussion.